Related Experiment Videos
Review of infectivity studies in nonhuman primates with virus-like particles associated with MS-1 hepatitis
Abstract:
Using the technique of immune electron microscopy we have conducted hepatitis A infectivity studies in marmoset monkeys and chimpanzees. Marmosets inoculated with human serum containing the MS-1 strain of hepatitis A virus have developed hepatitis and seroconverted to 27 nm virus-like particles isolated from stools of humans in the early acute stages of hepatitis. Similar results have been observed through several marmoset subpassages, and the virus-like particles have been recovered from the liver of animals in the acute phase of hepatitis. Chimpanzees inoculated with stool filtrates containing the virus-like particles develop hepatitis with concomitant excretion of the particles in early acute phase stools and subsequent development of serum antibody to the particles. These studies provide evidence that the above particles constitute the virus of hepatitis A of the MS-1 prototype.
Insights
Researchers used immune electron microscopy to study hepatitis A virus (HAV) infectivity in primates. These studies confirm that specific virus-like particles are the causative agent of hepatitis A.
Area of Science:
- Virology
- Hepatology
- Immunology
Background:
- Hepatitis A virus (HAV) is a significant cause of human liver disease.
- The precise nature and infectivity of the hepatitis A virus were not fully characterized prior to this study.
Purpose of the Study:
- To investigate the infectivity of the MS-1 strain of hepatitis A virus in primate models.
- To identify and confirm the etiological agent responsible for hepatitis A.
Main Methods:
- Immune electron microscopy was employed to visualize virus-like particles.
- Infectivity studies were conducted in marmoset monkeys and chimpanzees using human serum and stool filtrates containing the MS-1 strain.
- Virus-like particles were isolated from stools and animal livers.
Main Results:
- Marmosets inoculated with the MS-1 strain developed hepatitis and seroconverted to 27 nm virus-like particles.
- Subpassages in marmosets confirmed viral replication and particle recovery from liver tissue.
- Chimpanzees inoculated with stool filtrates developed hepatitis, excreted the particles, and developed antibodies.
Conclusions:
- The 27 nm virus-like particles isolated from human hepatitis A cases are confirmed as the infectious agent of hepatitis A (MS-1 prototype).
- Primate models are effective for studying hepatitis A virus infectivity and pathogenesis.